Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cassano

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Scientific Reports|November 23, 2021
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancerDonatella Lucchetti, Ina Valeria Zurlo, Filomena Colella, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2019
Pembrolizumab as first-line treatment for metastatic uveal melanomaErnesto Rossi, Monica Maria Pagliara, Daniela Orteschi, et al.
Cancers|July 31, 2019
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?Ernesto Rossi, Giovanni Schinzari, Ilaria Grazia Zizzari, et al.
European Radiology|September 30, 2020
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study)Roberto Iezzi, Roberto Cioni, Domenico Basile, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2021
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancerIna Valeria Zurlo, Mattia Schino, Antonia Strippoli, et al.
Journal of Personalized Medicine|April 3, 2021
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective AnalysisArmando Orlandi, Letizia Pontolillo, Caterina Mele, et al.
Clinical Epigenetics|January 9, 2019
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agentsRiccardo Ricci, Maurizio Martini, Gloria Ravegnini, et al.
Future Oncology (London, England)|May 7, 2014
Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinomaMaria Iole Natalicchio, Giuseppina Improta, Angela Zupa, et al.
European Journal of Radiology|April 22, 2019
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?Roberto Iezzi, Maurizio Pompili, Alessandro Posa, et al.
Vaccines|April 25, 2020
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need TrialAndrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Scientific Reports|November 23, 2021
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancerDonatella Lucchetti, Ina Valeria Zurlo, Filomena Colella, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2019
Pembrolizumab as first-line treatment for metastatic uveal melanomaErnesto Rossi, Monica Maria Pagliara, Daniela Orteschi, et al.
Cancers|July 31, 2019
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?Ernesto Rossi, Giovanni Schinzari, Ilaria Grazia Zizzari, et al.
European Radiology|September 30, 2020
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study)Roberto Iezzi, Roberto Cioni, Domenico Basile, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2021
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancerIna Valeria Zurlo, Mattia Schino, Antonia Strippoli, et al.
Journal of Personalized Medicine|April 3, 2021
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective AnalysisArmando Orlandi, Letizia Pontolillo, Caterina Mele, et al.
Clinical Epigenetics|January 9, 2019
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agentsRiccardo Ricci, Maurizio Martini, Gloria Ravegnini, et al.
Future Oncology (London, England)|May 7, 2014
Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinomaMaria Iole Natalicchio, Giuseppina Improta, Angela Zupa, et al.
European Journal of Radiology|April 22, 2019
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?Roberto Iezzi, Maurizio Pompili, Alessandro Posa, et al.
Vaccines|April 25, 2020
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need TrialAndrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Pageof 10